发明授权
US08993576B2 6-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereof
有权
6-（1H-吲哚-4-基）-4-（5 - {[4-1-甲基乙基] -1-哌嗪基]甲基} -1,3-恶唑-2-基）-1H-吲唑半琥珀酸盐 ，多晶型物及其药物组合物
![6-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereof](/docs/US/2015-03-31/US08993576B2/abs.jpg.600x600.jpg)
- 专利标题： 6-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereof
- 专利标题（中）： 6-（1H-吲哚-4-基）-4-（5 - {[4-1-甲基乙基] -1-哌嗪基]甲基} -1,3-恶唑-2-基）-1H-吲唑半琥珀酸盐 ，多晶型物及其药物组合物
-
申请号： US13879667申请日： 2011-10-25
-
公开(公告)号： US08993576B2公开(公告)日： 2015-03-31
- 发明人: Julie Nicole Hamblin , Paul Spencer Jones , Suzanne Elaine Keeling , Joelle Le , Nigel James Parr , Robert David Willacy
- 申请人： Julie Nicole Hamblin , Paul Spencer Jones , Suzanne Elaine Keeling , Joelle Le , Nigel James Parr , Robert David Willacy
- 申请人地址： GB Brentford, Middlesex
- 专利权人： Glaxo Group Limited
- 当前专利权人： Glaxo Group Limited
- 当前专利权人地址： GB Brentford, Middlesex
- 代理商 Robert J. Smith
- 优先权： GB1018124.6 20101027
- 国际申请： PCT/EP2011/068604 WO 20111025
- 国际公布： WO2012/055846 WO 20120503
- 主分类号： A61K31/496
- IPC分类号： A61K31/496 ; C07D413/14
![6-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereof](/abs-image/US/2015/03/31/US08993576B2/abs.jpg.150x150.jpg)
摘要：
The present invention is directed to a polymorph of a compound and salts of a compound and polymorphs thereof, which compound is an inhibitor of kinase activity.
公开/授权文献
- US20130203772A1 Polymorphs and Salts 公开/授权日：2013-08-08
信息查询
IPC分类:
